Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06778070 · ClinicalTrials.gov registry record · NA

National Program to Overcome Pelvic Pain studY (POPPY)

A NA study of Chronic Pelvic Pain Syndrome and Chronic Pelvic Pain, sponsored by University of California, San Francisco.

Recruiting
Registry status
NA
Development phase
220
Enrollment target
1
Study location

NCT06778070 is a NA study of Chronic Pelvic Pain Syndrome and Chronic Pelvic Pain that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 220 participants, above the 177-participant average among 11 other Chronic Pelvic Pain Syndrome trials with a reported enrollment target (24% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06778070, a NA study of Chronic Pelvic Pain Syndrome and Chronic Pelvic Pain, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
NA
Development phase
220 participants
Enrollment target
1
Study location

Study Summary

A randomized, parallel-group, investigator-blinded, comparative effectiveness trial of a fully remote, videoconference-based pelvic floor yoga program versus a physical conditioning program for women with chronic pelvic pain syndrome.

Interventions

  • OTHER Pelvic floor yoga
  • OTHER Physical conditioning

Study Locations (1)

California

  • University of California San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 220 participants
Start Date 2025-05-12
Est. Completion 2029-03-15
Phase NA

What the Registry Record Tells You About NCT06778070

The ClinicalTrials.gov registry entry for NCT06778070 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 177-participant average among 11 other Chronic Pelvic Pain Syndrome trials with a reported enrollment target (24% higher). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Chronic Pelvic Pain Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Pelvic floor yoga is the first listed.

NCT06778070 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06778070 about?

NCT06778070 is a clinical study titled "National Program to Overcome Pelvic Pain studY (POPPY)". A randomized, parallel-group, investigator-blinded, comparative effectiveness trial of a fully remote, videoconference-based pelvic floor yoga program versus a physical conditioning program for women with chronic pelvic pain syndrome.

What is the current status of trial NCT06778070?

This trial is currently recruiting. It is a NA study. The enrollment target is 220 participants. The study started on 2025-05-12. Estimated completion is 2029-03-15.

What conditions does trial NCT06778070 study?

This clinical trial studies the following conditions: Chronic Pelvic Pain Syndrome, Chronic Pelvic Pain, Chronic Pelvic Pain Syndrome (CPPS).

What interventions are being tested in trial NCT06778070?

The interventions under investigation include: Pelvic floor yoga (OTHER), Physical conditioning (OTHER).

Who is sponsoring clinical trial NCT06778070?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06778070 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pelvic Pain Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.